Understanding the status of PTEN expression across the spectrum of endometrial lesions can provide valuable insights into the molecular pathogenesis of endometrial carcinoma and may offer prognostic and potentially therapeutic implications. The gene discussed is PTEN; the disease is endometrial carcinoma.